Devika Das News Today

For budding entrepreneurs, success often hinges on securing essential funding, so meticulous preparation is key when gearing up to pitch ideas to potential investors.

The Hyderabad Literary Festival 2024 is all set to begin from tomorrow at Sattva Knowledge City, HITEC City,

Artists are needed to keep central streets alive.

Devika Das, MD, MSHQS, discusses the use of neoadjuvant and adjuvant chemoimmunotherapy for patients with resectable non–small cell lung cancer, and emphasizes the importance of multidisciplinary collaboration when incorporating these regimens into treatment approaches.

Devika Das, MD, MSHQS, discusses the activity and tolerability of lurbinectedin and topotecan as second-line regimens in extensive-stage small cell lung cancer.

Devika Das, MD, MSHQS,discusses updated data on the use of immunotherapy and platinum-based chemotherapy regimens in extensive-stage small cell lung cancer.

/PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) is pleased to announce the appointment of a select group of volunteers to its newly formed Education...

While we are at home amid the second wave of the pandemic, the readers should not miss their favourite books.

 E-Mail DURHAM, N.C. - A study designed to enroll an equal number of Black and white men with advanced prostate cancer confirms key findings that have been evident in retrospective analyses and suggest potential new avenues for treating Black patients who disproportionately die of the disease. Researchers at Duke Cancer Institute enrolled 50 Black and 50 white men with advanced prostate cancer to test whether there were outcome differences on treatment with the hormone therapy abiraterone acet...

With new funding from the Veterans Affairs VA Lung Precision Oncology Program, Winship Cancer Institute of Emory University (Winship) will provide thoracic oncology expertise to help three VA medical centers expand access to high quality, disease altering lung cancer clinical trials to veterans in the Southeast. This five-year project is supported by $5 million in funding. It involves six investigators from three VA medical centers and their cancer centers partners. They are: Charleston/MUSC H...